INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
|
153.61 |
137.11 |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
|
- |
- |
Other Revenue |
- |
- |
|
-0.55 |
- |
Total Revenue |
156.24 |
128.28 |
206.25 |
153.07 |
137.11 |
Cost of Goods and Services Sold |
115.74 |
98.22 |
150.97 |
113.00 |
109.69 |
Gross
Profit |
40.50 |
30.05 |
55.28 |
40.07 |
27.42 |
Selling, Administration, Marketing |
30.40 |
30.95 |
30.25 |
25.59 |
26.64 |
Depriciation & Amortization |
0.14 |
0.05 |
0.05 |
0.05 |
0.05 |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
0.00 |
- |
- |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
146.28 |
129.22 |
181.26 |
138.64 |
136.38 |
Operating income/-loss
|
9.96 |
-0.94 |
24.99 |
14.43 |
0.73 |
Other Deductions / - Income |
Interest expense |
- |
0.16 |
0.37 |
0.59 |
0.77 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
0.16 |
0.37 |
0.59 |
0.77 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
1.00 |
0.17 |
-0.01 |
0.65 |
-0.27 |
Total costs & expenses |
147.28 |
129.55 |
181.62 |
139.88 |
136.89 |
Income /-loss before income taxes |
8.96 |
-1.27 |
24.63 |
13.19 |
0.22 |
Income taxes expenses/-benefit |
2.97 |
-0.11 |
5.06 |
2.85 |
0.11 |
Income after income taxes |
5.99 |
-1.16 |
19.57 |
10.34 |
0.11 |
Net income/-loss
of other equity |
0.00 |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
5.99 |
-1.16 |
19.57 |
10.34 |
0.11 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
5.99 |
-1.16 |
19.57 |
10.34 |
0.11 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
5.99 |
-1.16 |
19.57 |
10.34 |
0.11 |
EBIT |
8.96 |
-1.12 |
24.99 |
13.78 |
1.00 |
EBITD |
10.40 |
0.07 |
26.28 |
14.73 |
2.12 |
EBITDA |
10.40 |
0.07 |
26.28 |
14.73 |
2.12 |